Browse by intervention

Ezetimibe: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

How to read this

Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.

Read the full methods and limits

Key findings

Phoenix has measured Ezetimibe against 5 exact outcomes for APOE4 carriers. Member #29E727 lowered ApoB from 131 to 90 mg/dL in 133 days on an ezetimibe-led combination. Member #6FAEFA's HDL cholesterol moved from 74 to 89 mg/dL in 70 days. Three members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination. The same three members' total cholesterol fell alongside their LDL cholesterol. Member #B50FCD's Triglycerides moved from 59.4 to 46.9 mg/dL in 85 days.

Ezetimibe evidence by outcome
OutcomeDirectionWhat we observed
Apolipoprotein BRepeated positiveMember #29E727 lowered ApoB from 131 to 90 mg/dL in 133 days on an ezetimibe-led combination.
HDL cholesterolRepeated positiveMember #6FAEFA's HDL cholesterol moved from 74 to 89 mg/dL in 70 days.
LDL cholesterolRepeated positiveThree members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination.
Total cholesterolRepeated positiveThe same three members' total cholesterol fell alongside their LDL cholesterol.
TriglyceridesPositive individual resultMember #B50FCD's Triglycerides moved from 59.4 to 46.9 mg/dL in 85 days.

Is ezetimibe a good option for carriers, alone or with other drugs, and does it protect the brain?

Ezetimibe lowers LDL and ApoB and, added to other treatment, lowers heart attacks and strokes; it works similarly in APOE4 carriers. Whether it protects the brain is unknown: one health-record study found far less dementia, but a genetic study found no effect on Alzheimer's risk. It is a prescription decision; ask your doctor whether it fits your ApoB goal.

What the research says

Grade A

APOE4-specific evidence: limited

Ezetimibe lowers LDL and ApoB and cuts cardiovascular events (high certainty); any brain benefit is unproven.

Key studies

4 more key studies
  • Leosdottir 2025, J Am Coll Cardiol (SWEDEHEART)

    Registry after heart attack: adding ezetimibe early went with fewer later cardiovascular events than adding it late or never.

    Read on PubMed (opens in a new tab)
  • Mark 2007, Curr Med Res Opin

    Small open-label study: ezetimibe lowered LDL similarly in APOE4 carriers and APOE3/3.

    Read on PubMed (opens in a new tab)
  • Ganne 2024, Aging BiolGrade C

    Health-record analysis plus lab models: ezetimibe use linked to sevenfold lower Alzheimer's and related dementia; observational.

    Read on PubMed (opens in a new tab)
  • Williams 2020, Ann NeurolGrade C

    Genetic study: variants mimicking ezetimibe (NPC1L1) did not change Alzheimer's risk.

    Read on PubMed (opens in a new tab)

What Kevin and experts say

5 passages for, 3 with a caution, 3 also discussed

Now showing: Dr. Kevin Tran · 0:04

Open on YouTube (opens in a new tab)

For5 passages

  1. 0:04How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Kevin's ApoB fell nearly 40% with ezetimibe stacked with diet and fibre.

    “when I first had my apoB measured, it was 115 mg per deciliter. Today, it's slightly below 70, and that's a drop of nearly 40%.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 21:57How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Ezetimibe alone cut heart events 34% in older adults.

    “Basically a 34% reduction in cardiovascular events on ezetimibe alone, no statin.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  3. 22:30How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Ezetimibe works for APOE4 carriers too.

    “The LDL reduction in [APOE3/3] was 22.8% and in APOE4 carriers it was 19.6%.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  4. 21:52APOE4 & Lipids: Why Your Doctor's Targets Aren't Aggressive Enough (Statin Debate Settled?) ·

    Ezetimibe is safe and effective for cholesterol.

    “it's a good medication for lipid optimization. It's safe. It's well tolerated.”

    Dr. Grant Fraser, Board-certified anti-aging and family medicine physician, APOE4 carrier

  5. ShortEzetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Ezetimibe plus other changes cut Kevin's ApoB nearly 40%.

    Dr. Kevin Tran

    Watch the Short on YouTube (opens in a new tab)

With a caution3 passages

  1. 38:47How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Watch liver enzymes on ezetimibe.

    “sometime ezetimibe can nudge liver enzymes”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 21:20APOE4 & Lipids: Why Your Doctor's Targets Aren't Aggressive Enough (Statin Debate Settled?) ·

    Fraser: ezetimibe doesn't reach the brain, so a brain benefit is doubtful.

    “And when we're taking ezetimibe it's definitely not getting into the brain.”

    Dr. Grant Fraser, Board-certified anti-aging and family medicine physician, APOE4 carrier

  3. Short1 Million People Just Linked Ezetimibe's Target to Lower Dementia Risk ·

    Big signal for ezetimibe, but only observational.

    Dr. Kevin Tran

    Watch the Short on YouTube (opens in a new tab)

Also discussed3 passages

  1. 20:30How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Ezetimibe blocks cholesterol absorption in the gut.

    “Ezetimibe works in the gut by blocking a protein called NPC 1L1”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 23:13How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    A huge dementia signal for ezetimibe, but only observational.

    “ezetimibe was associated with a sevenfold reduction in Alzheimer's and related dementia risk”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  3. ShortEzetimibe Is NOT a Statin — Different Organ, Different Enzyme ·

    Ezetimibe lowers cholesterol by blocking gut absorption, not liver production.

    Dr. Kevin Tran

    Watch the Short on YouTube (opens in a new tab)

Last reviewed

Questions about Ezetimibe

What is the effect of Ezetimibe for APOE4 carriers?

Phoenix has measured Ezetimibe against 5 exact outcomes for APOE4 carriers. Member #29E727 lowered ApoB from 131 to 90 mg/dL in 133 days on an ezetimibe-led combination. Member #6FAEFA's HDL cholesterol moved from 74 to 89 mg/dL in 70 days. Three members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination. The same three members' total cholesterol fell alongside their LDL cholesterol. Member #B50FCD's Triglycerides moved from 59.4 to 46.9 mg/dL in 85 days.

Does Ezetimibe change Apolipoprotein B for APOE4 carriers?

Member #29E727 lowered ApoB from 131 to 90 mg/dL in 133 days on an ezetimibe-led combination. Support: 2 logged members, 2 members with repeats, 2 observations, 4 measurements.

Does Ezetimibe change HDL cholesterol for APOE4 carriers?

Member #6FAEFA's HDL cholesterol moved from 74 to 89 mg/dL in 70 days. Support: 4 logged members, 4 members with repeats, 4 observations, 8 measurements.

Does Ezetimibe change LDL cholesterol for APOE4 carriers?

Three members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination. Support: 4 logged members, 4 members with repeats, 4 observations, 8 measurements.

Does Ezetimibe change Total cholesterol for APOE4 carriers?

The same three members' total cholesterol fell alongside their LDL cholesterol. Support: 5 logged members, 5 members with repeats, 5 observations, 10 measurements.

Does Ezetimibe change Triglycerides for APOE4 carriers?

Member #B50FCD's Triglycerides moved from 59.4 to 46.9 mg/dL in 85 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.

What changed for real APOE4 carriers?

Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.

Want to see how this affects you? Phoenix tracks it beside your labs and how you feel.

Apply to join Phoenix

Ezetimibe · 5 outcomes shown.

Intervention categoryMedications
InterventionEzetimibe

Ezetimibe

MedicationsOutcomes: 5

Apolipoprotein B: Decrease 36–41 mg/dL

Cases: 2Case range

HDL cholesterol: Increase 9–15 mg/dL

Cases: 4Case range

LDL cholesterol: Decrease 22–52 mg/dL

Cases: 4Case range

Total cholesterol: Decrease 14.9–79 mg/dL

Cases: 5Case range

Triglycerides: Decrease 12.5 mg/dL

Cases: 1

The Beat the Odds Study

The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.

Download the Beat the Odds Study

Turn evidence into your next test

I built this so nobody has to be the first to try something.

476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.

Apply to join Phoenix

Full research index

Find a goal, marker, intervention or question

Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.